Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Category: News

Serac’s imaging agent marks a breakthrough in endometriosis detection

Serac’s imaging agent marks a breakthrough in endometriosis detection
p p Read More

Early-stage endometriosis now visible through non-invasive imaging

June 7, 2024 data, endometriosis, News, serac

Boehringer Ingelheim’s survodutide shows promise in liver fibrosis treatment

Boehringer Ingelheim’s survodutide shows promise in liver fibrosis treatment
p p Read More

Phase 2 trial reveals significant improvement in MASH patients

June 7, 2024 boehringeringelheim, liver, News, survodutide

Amgen’s trial brings new hope for IgG4-RD patients

Amgen’s trial brings new hope for IgG4-RD patients
p p Read More

Inebilizumab shows sound efficacy in landmark research

June 6, 2024 Amgen, igg4-rd, Inebilizumab, News

Alchemab receives funding boost for Parkinson’s research

Alchemab receives funding boost for Parkinson’s research
p p Read More

Innovative antibody discovery could lead to new Parkinson’s treatments

June 6, 2024 Alchemab, Funding, News, parkinsons

Sanofi’s Sarclisa shows significant promise in treating myeloma

Sanofi’s Sarclisa shows significant promise in treating myeloma
p p Read More

Phase 3 research suggests a significant leap forward in myeloma management

June 5, 2024 myelma, News, Sanofi, Sarclisa

Resolution unveils data for liver disease treatment at EASL 2024

Resolution unveils data for liver disease treatment at EASL 2024
p p Read More

Extended phase 2 study highlights macrophage cell therapy’s efficacy

June 5, 2024 liver, News, resolution therapeutics, University of Edinburgh

EpiEndo and AlveoliX achieve milestone in ulcerative colitis treatment

EpiEndo and AlveoliX achieve milestone in ulcerative colitis treatment
p p Read More

Collaboration yields promising Barriolide therapy Enterothelin

June 4, 2024 AlveoliX, EpiEndo, News, UC

invoX Pharma’s FS222 delivers encouraging solid tumour treatment results

invoX Pharma’s FS222 delivers encouraging solid tumour treatment results
p p Read More

Positive clinical data from phase 1 study presented at ASCO annual meeting

June 4, 2024 fs222, invox, News, solid tumours

New UCL-developed immunotherapy shows promising results in treating bone cancer

New UCL-developed immunotherapy shows promising results in treating bone cancer
p p Read More

Bone cancer affects more than 150,000 people in the UK and is often resistant to chemotherapy

June 3, 2024 bone cancer, News, OPS-gdT, osteosarcoma, University College London

International KCL research project to develop SMARTdrugs for aggressive cancers

International KCL research project to develop SMARTdrugs for aggressive cancers
p p Read More

The platform will be used to diagnose and treat cancers, including lung and brain tumours

June 3, 2024 aggressive cancer, King’s College London, lung cancer, News, Oncology, SMARTdrugs, supramolecular compounds

Posts navigation

Posts pagination

« Previous 1 … 36 37 38 … 59 Next »
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy